Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neurogene (NGNE) Current Assets (2018 - 2025)

Historic Current Assets for Neurogene (NGNE) over the last 6 years, with Q3 2025 value amounting to $270.5 million.

  • Neurogene's Current Assets rose 8832.21% to $270.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $270.5 million, marking a year-over-year increase of 8832.21%. This contributed to the annual value of $315.9 million for FY2024, which is 5768.71% up from last year.
  • Per Neurogene's latest filing, its Current Assets stood at $270.5 million for Q3 2025, which was up 8832.21% from $279.0 million recorded in Q2 2025.
  • Over the past 5 years, Neurogene's Current Assets peaked at $315.9 million during Q4 2024, and registered a low of $79.9 million during Q3 2023.
  • Moreover, its 3-year median value for Current Assets was $174.1 million (2024), whereas its average is $189.9 million.
  • Over the last 5 years, Neurogene's Current Assets had its largest YoY gain of 10335.02% in 2024, and its largest YoY loss of 5768.71% in 2024.
  • Neurogene's Current Assets (Quarter) stood at $200.3 million in 2023, then skyrocketed by 57.69% to $315.9 million in 2024, then dropped by 14.37% to $270.5 million in 2025.
  • Its Current Assets stands at $270.5 million for Q3 2025, versus $279.0 million for Q2 2025 and $296.4 million for Q1 2025.